LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carlos Rodriguez-Galindo, MD
North American Consortium for Histiocytosis
Study Chair - Milen Minkov, MD, Ph.D
Children's Cancer Research Institute / St. Anna Children's Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S of Alabama
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Valley Children'S Healthcare
Madera, California, United States
- Ucsf Benioff Children'S Hospital of Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Helen Diller Family Cancer Center
San Francisco, California, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Healthcare of Atlanta, Emory
Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Riley Hospital for Children - Indiana University
Indianapolis, Indiana, United States
- Children'S Mercy Hospitals
Kansas City, Kansas, United States
- University of Kentucky A.B.Chandler Medical Center
Lexington, Kentucky, United States
- University of Louisville, Norton Children'S Hospital
Louisville, Kentucky, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Children'S Minnesota
Minneapolis, Minnesota, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Cohen Children'S Medical Center
New Hyde Park, New York, United States
- Columbia University / Herbert Irving Cancer Center
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Mount Sinai Hospital
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Children'S Hospital at Montefiore
The Bronx, New York, United States
- Carolinas Medical Center, Levine Children'S Hospital
Charlotte, North Carolina, United States
- Akron Children'S Hospital
Akron, Ohio, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Rainbow Babies & Children'S Hospital, University Hospitals
Cleveland, Ohio, United States
- Russell J Ebeid Children'S Hospital (promedica)
Toledo, Ohio, United States
- Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Medical University of South Carolina (musc)
Charleston, South Carolina, United States
- Greenville Health System Bi-Lo Charities Children'S Cancer Center
Greenville, South Carolina, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Children'S Medical Center Dallas, Ut Southwestern
Dallas, Texas, United States
- Providence Sacred Heart Children'S Hospital
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Nov 2016
- Primary completion
- 31 Jul 2026
- Completion
- 31 Jul 2026
- Last update posted
- 9 Apr 2026
- Registered enrollment
- 1,400
- Registry id
- NCT02205762
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.